Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Obesity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02959762
What this trial is testing

Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)

Who this might be right for
ObesityInsulin ResistanceObesity in Diabetes+4 more
Augusta University 30
Not applicableLooking for participantsNCT01984762
What this trial is testing

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.

Who this might be right for
ObesityType 2 DiabetesBariatric Surgery
Göteborg University 134
Not applicableActive Not RecruitingNCT07538362
What this trial is testing

Intervention Based on the Dietary Guidelines for the Brazilian Population for the Treatment of Overweight and Obesity

Who this might be right for
Obesity & OverweightOverweight (BMI > 25)
Federal University of Health Science of Porto Alegre 60
Not applicableStudy completedNCT01983046
What this trial is testing

Rectal Short Chain Fatty Acids Combinations and Substrate and Energy Metabolism

Who this might be right for
ObesityType 2 Diabetes
Maastricht University Medical Center 12
Not applicableUnknownNCT05857059
What this trial is testing

Misoprostol for Induction of Labor in Obese Women: Comparison Between 25 and 50 mcg Oral Administration

Who this might be right for
Labor, InducedObesityPregnancy+1 more
Unidade Local de Saúde de Coimbra, EPE 228
Not applicableLooking for participantsNCT06152588
What this trial is testing

Restricted Eating Time in the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Steno Diabetes Center Copenhagen 160
Testing effectiveness (Phase 2)Looking for participantsNCT05746039
What this trial is testing

Feasibility of Semaglutide in Advanced Lung Disease

Who this might be right for
ObesityInterstitial Lung DiseaseChronic Obstructive Pulmonary Disease+2 more
University of Pennsylvania 8
Not applicableStudy completedNCT03939442
What this trial is testing

Evaluation of Patients Who Underwent Sleeve Gastrectomy With Jejunoileal Anastomosis for the Treatment of Morbid Obesity

Who this might be right for
Sleeve Gastrectomy With Jejunoileal Anastomosis
Inonu University 2
Testing effectiveness (Phase 2)Ended earlyNCT01756105
What this trial is testing

Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women

Who this might be right for
Gestational DiabetesMetforminTreatment+1 more
University Hospital, Strasbourg, France 84
Not applicableStudy completedNCT05158075
What this trial is testing

Program for the Comprehensive Neurocognitive Treatment of Excess Weight

Who this might be right for
ObesityOverweight
Raquel Vilar López 150
Not applicableLooking for participantsNCT07633639
What this trial is testing

GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity

Who this might be right for
Obesity
China-Japan Friendship Hospital 200
Not applicableStudy completedNCT01096719
What this trial is testing

The Healthy Eating Choices for Life Program

Who this might be right for
Obesity
The University of Tennessee, Knoxville 45
Not applicableLooking for participantsNCT06671119
What this trial is testing

REvision of VSG with Ablation of the Mucosa Procedure

Who this might be right for
Obesity and Obesity-related Medical ConditionsObesity and OverweightObesity Prevention+1 more
Dr. Christopher McGowan 5
Post-approval studies (Phase 4)Study completedNCT06027567
What this trial is testing

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Who this might be right for
Idiopathic Intracranial HypertensionIntracranial PressureObesity+3 more
Rigmor Højland Jensen 38
Not applicableStudy completedNCT01662557
What this trial is testing

Treatment of Early Childhood Overweight in Primary Care: Pilot Study

Who this might be right for
Obesity
University of Pennsylvania 51
Not applicableActive Not RecruitingNCT06520657
What this trial is testing

Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers

Who this might be right for
Child ObesitySocial Determinants of Health
Children's Mercy Hospital Kansas City 120
Post-approval studies (Phase 4)Temporarily pausedNCT05209165
What this trial is testing

Semaglutide to Reduce Atrial Fibrillation Burden

Who this might be right for
Atrial FibrillationObesityOverweight
San Francisco Veterans Affairs Medical Center 132
Testing effectiveness (Phase 2)Study completedNCT06640972
What this trial is testing

Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists

Who this might be right for
TriglyceridesWeight Gain TrajectoryCholesterol, Elevated
Response Pharmaceuticals 68
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Not applicableStudy completedNCT00539487
What this trial is testing

Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives

Who this might be right for
HypertensionObesity
Boehringer Ingelheim 5,827
Next Page